Loading people...
Linda Greub is the Co-Founder and Managing Partner of Avestria Ventures, a life sciences venture capital firm based in the Bay Area. She began her career in institutional finance, working as a healthcare research analyst at Banc of America Securities and managing investments at two private hedge funds, Tudor Investment Corporation and Essex Investment Management. Transitioning into the biotechnology sector, Greub held corporate development and finance leadership roles at several prominent organizations, including Novartis Diagnostics and Applied Biosystems. During her operational tenure, she contributed to significant industry consolidation, participating in the sale of Applied Biosystems to Life Technologies and the acquisition of Raindance by Bio-Rad. The Harvard Business School graduate and CFA charterholder also serves on the Women’s Health Executive Committee for Springboard Enterprises. Her current investment strategy focuses on advancing early-stage life sciences and women's health companies.
Linda Greub stands as a prominent figure in the venture capital landscape, serving as the Managing Partner at Avestria Ventures. As a co-founder of the firm, she has been instrumental in shaping its mission to address the significant funding gap and innovation deficit within women's health. Under her leadership, Avestria Ventures has emerged as a leading investor in companies dedicated to improving health outcomes for women across various life stages.
At Avestria Ventures, Linda Greub's investment focus is broad yet specialized, encompassing the rapidly evolving sectors of femtech, digital health, diagnostics, medical devices, and therapeutics specifically designed for women. She champions companies that are developing groundbreaking solutions, from fertility and maternal care to menopause management, chronic conditions affecting women, and preventative health. Her strategic vision ensures that Avestria supports ventures poised to make a tangible impact on women's well-being and healthcare access.
Linda's extensive career background provides a robust foundation for her role at Avestria Ventures. Prior to co-founding Avestria, she accumulated significant experience in finance and investment banking, holding key positions at prestigious institutions such as JPMorgan and Credit Suisse. This background equipped her with a deep understanding of market dynamics, financial structuring, and strategic growth, all of which she now leverages to identify and nurture promising healthcare startups. Her transition into venture capital, particularly with a focus on women's health, reflects a passionate commitment to an underserved market.
While specific individual investments by Linda Greub are part of Avestria Ventures' collective portfolio, the firm has made notable investments in companies that exemplify its mission. These include innovators in areas like personalized women's health diagnostics, digital platforms for comprehensive reproductive health, and novel medical devices addressing specific female health conditions. Linda's guidance helps these portfolio companies navigate the complex healthcare landscape, scale their operations, and ultimately bring their vital solutions to market. Her work at Avestria Ventures is not just about financial returns, but about driving meaningful change and fostering a healthier future for women worldwide.
Linda Greub is the Managing Partner at Avestria Ventures, a venture capital firm specializing in women's health. She is a key leader in the femtech and healthcare investment landscape, co-founding the firm to address unmet needs in women's healthcare.
Linda Greub invests in innovative companies focused on women's health through Avestria Ventures. Her investment areas include femtech, digital health, diagnostics, medical devices, and therapeutics designed to improve women's health outcomes across various life stages.
Linda Greub works as the Managing Partner at Avestria Ventures, a dedicated venture capital firm she co-founded. Avestria Ventures focuses exclusively on investing in the women's health sector.
